G Medical Innovations Holdings Ltd announced that it has entered into a securities purchase agreement with a single institutional investor for a private placement of 2,400,000 common shares or pre-funded warrants in lieu thereof at an issue price of $5 per share for gross proceeds of $12,000,000 on January 30, 2022. As part of transaction the company will also issue warrants to purchase up to an aggregate of 2,400,000 common shares at an exercise price of $5 per share, will be exercisable immediately upon issuance and will have a term of five (5) years. The closing of the transaction is expected to occur on or about February 2, 2022, subject to the satisfaction of customary closing conditions.

The company will issue securities pursuant to the exemption provided under Regulation D.